I talked about Cordlife in my previous post. To keep you updated on the recent bulletin released by Dr. Arvin Faundo, Medical Directorof Cordlife Philippines, I decided to make a follow up post on it. Dr. Faundo talked about the latest prenatal stem cell technology that can become the key to potential cure to diseases. The following are important details for your added information.
CordLife was established to provide a full suite of cord blood and tissue banking services,which include the collection, processing and cryo preservation storage of cordblood stem cells and umbilical cord tissue. Since its inception in 2001,CordLife has grown rapidly from a fledging start-up company to the largest network of cord blood banks in the Asia-Pacific region. Our in-depth knowledge of cord blood banking practices and standards has developed strong capabilitiesto attain certifications from quality standard organizations such as the International Organization for Standardization (ISO) and country regulators.The prestigious “Technology Pioneer” title awarded by the World Economic Forum ascertained our outstanding performance in the industry.
Today, the CordLifegroup of companies (CordLife Limited) is listed on the Australian Securities Exchange (ASX:CBB),which owns and operates cord blood processing and tissue storage facilities situated in Indonesia, India, and the Philippines.